CD45-deficient cell lines were generated using the pX330 vector (38) and guide RNAs targeting CD45 (59). The pX330 vector was introduced using electroporation and cultured for ~4 days. Cells were stained for surface CD45, and cells with low CD45 expression were sorted into 96-well plates using a BD FACSAria. Cells were expanded and analyzed for CD45 expression using flow cytometry and immunoblot to confirm CD45-deficient clones. Mutations to PTPRC, which encodes CD45, were confirmed by sequencing. The target site was amplified by polymerase chain reaction using genomic DNA isolated from cell lines and cloned into a Topo vector. Cell lines that were reconstituted with CskAS were confirmed by immunoblot using anti-Csk and anti-Myc tag antibodies.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.